Facebook
Twitter
LinkedIn
Forward
Highlights of ASH 2023
Registration closes at 5:00 pm February 28th
Registrant Refund Policy:
Eligibility for a registrant refund is based on the following criteria. Please note, all registrants must email CME department within the specified time frames to be eligible for a refund. To receive a full refund, registrants must provide written notification to the CME department no sooner than 30 days of activity start date. Registrants that notify the CME department within 14-29 days prior to activity will receive a 50% refund.
Notification Qualifications | Refund Amount |
30+ days prior to activity | 100% Refund |
14-29 days prior to activity | 50% Refund |
Less than 14 days prior to activity | No Refund |
Conference will be be able to provide to participants an overview and highlight the cutting edge data presented at the 2023 Annual Meeting of the American Society of Hematology (ASH) after attending this conference. In person only attendance
| Industry Attendee | $500 |
| Physicians | $125 |
| AHN Physicians | $80 |
| Nurses and Others | $65 |
| AHN Nurses and others | $45 |
| Residents and Fellows | Complimentary |
Target Audience
This conference is intended for primary care physicians, hematologists and medical oncologists, fellows, residents, certified registered nurse practitioners, physician assistants, nurses, and all other health
care providers.
Learning Objectives
- Discuss the cutting edge data presented at the 2023 Annual Meeting of the American Society of Hematology (ASH)
- Identify updates in molecular abnormalities which can be utilized in the diagnosis, prognosis, risk stratification and therapy selection for patients with myeloid malignancies.
- Discuss and assess the relevant clinical trial data in clinical practice which has the potential to improve outcomes in patients with malignant hematologic disorders including Non-Hodgkin's Lymphoma, CLL, and Multiple Myeloma
- Review the updates in sequencing strategies in the era of novel immunotherapies, CAR-T, targeted therapies and stem cell transplantation
- Discuss the latest advances in coagulation and platelet disorders
Additional Information
| Attachment | Size |
|---|---|
 MX3288469_CME_ASH2023_BRO_FS.pdf | 372.18 KB |
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through joint Providership of Allegheny General Hospital and AHN Cancer Institute West Penn Hospital. Allegheny General Hospital is accredited by the ACCME to provide continuing medical education for physicians.
Approved for 6.0 AMA PRA Category 1 Credits TM
Available Credit
- 6.00 AMA PRA Category 1 Credit™
- 6.00 Attendance